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A Measles Vaccine Withdrawn
The decision last week by Burroughs Wellcome to withdraw their measles vaccine (Wellcovax)l came as a surprise to many general practitioners and medical officers of health who had used it during the past year. Administration of this brand of measles vaccine has already been extensive. Well over a million doses have been given in Great Britain alone, and even larger amounts-perhaps as many as four million doses -have been used overseas. Burroughs Wellcome are not the only manufacturers of measles vaccine in this country. Vaccine prepared by Glaxo Laboratories is also in common use here, and preparations from other manufacturers are employed on a huge scale throughout the world. So far it is only the Wellcome preparation among the live vaccines in current use whose safety has been called in question.
It is too soon to assess fully the circumstances which led to withdrawal of the vaccine, but the immediate cause was the reports during recent months of three cases of encephalitis in young children soon after immunization. Doubtless in deciding to withdraw the vaccine the strain of virus it contains, the general severity of the response to the vaccine, and the need for extreme caution in the face of reports of untoward reactions have all been taken into account.
The Wellcome and Glaxo preparations differ in that the former contains the Beckenham 20 strain of attenuated measles virus and the latter the Schwartz strain. While both have a common ancestry in a strain called Edmonston B, field trials and routine experience alike have consistently shown that the Schwartz strain is the more attenuated of the two. Fever, malaise, and rash are undoubtedly less frequent with it. Considered solely from the point of view of the avoidance of reactions, the Schwartz strain is clearly superior, but what of the relative duration of protection conferred by the two vaccines ? Might immunization with the less attenuated Beckenham strain prove of greater benefit in the long term by producing a more durable protection ? This possibility has to be taken into account when the relative advantages of different strains are assessed.
With many of the live vaccines that have been in use for a number of years, such as those against yellow fever, smallpox, and poliomyelitis, a high measure of success has been achieved in obtaining a fine balance between safety and efficacy. Even so, these vaccines still carry a certain degree of risk. Progressive generalized vaccinia sometimes follows smallpox vaccination, and may be fatal; paralytic poliomyelitis may very occasionally occur after administering live poliovirus vaccine; encephalitis has been a problem with yellow-fever vaccine, especially with the Dakar strain. Some of the risks can be reduced by careful attention to certain contraindications for the use of vaccine, but even so the medical profession can never lose sight of the fact that the inoculation of live organisms, even though attenuated, always carries some risk.
The fever and iash which occurred in some children after receiving the Wellcome vaccine were not usually sufficient to be a cause for serious concern, but the association of vaccination and encephalitis, however infrequent, is a very different matter. Encephalitis is a well-known complication of natural measles. Its occurrence after immunization with strains of virus which are less attenuated may well be less remote than with strains in which attenuation is demonstrably more advanced. However, it must also be remembered that encephalitis occurs as a result of natural viral infection in the absence of vaccination. As the number of vaccinations increases so do the opportunities for encephalitis coincidental with, but not caused by, the vaccine, and thus the difficulty of distinguishing causation from association grows.
The prompt decision by Burroughs Wellcome to withdraw their vaccine was thus a sensible precaution, but it would be unfortunate if this were to prejudice the future of measles
